Metraipolis › archive › dc_e893796e8a29
Cannabinoids in Alzheimer's disease: animal-human evidence and clinical pharmacology challenges — Europe PMC PMID:42211879
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42211879
- DOI
- 10.3389/fnbeh.2026.1833021
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T07:35:14.277Z
- SHA-256 of the archived text
d78966b91167815347842610ece985d65268187f8a8a1765c8efd80eef261f16- Stable URL of this page
https://metraipolis.com/documento/dc_e893796e8a29
How to cite
Cannabinoids in Alzheimer's disease: animal-human evidence and clinical pharmacology challenges — Europe PMC PMID:42211879 — Europe PMC (en), https://europepmc.org/article/MED/42211879 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e893796e8a29 (Metraipolis archive dc_e893796e8a29, sha256 d78966b91167815347842610ece985d65268187f8a8a1765c8efd80eef261f16)
BibTeX
@misc{dce893796e8a29,
title = {Cannabinoids in Alzheimer's disease: animal-human evidence and clinical pharmacology challenges — Europe PMC PMID:42211879},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42211879},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e893796e8a29; sha256 d78966b91167815347842610ece985d65268187f8a8a1765c8efd80eef261f16},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42211879. Agents can read the archived copy with the MCP tool read_document.